BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 24597899)

  • 1. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.
    Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A
    BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting lactate production and efflux in prostate cancer.
    Pereira-Nunes A; Simões-Sousa S; Pinheiro C; Miranda-Gonçalves V; Granja S; Baltazar F
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165894. PubMed ID: 32650130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
    Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
    Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure.
    Andersen S; Solstad Ø; Moi L; Donnem T; Eilertsen M; Nordby Y; Ness N; Richardsen E; Busund LT; Bremnes RM
    Urol Oncol; 2015 Aug; 33(8):338.e9-17. PubMed ID: 26066969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.
    Fiaschi T; Marini A; Giannoni E; Taddei ML; Gandellini P; De Donatis A; Lanciotti M; Serni S; Cirri P; Chiarugi P
    Cancer Res; 2012 Oct; 72(19):5130-40. PubMed ID: 22850421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.
    Diehl K; Dinges LA; Helm O; Ammar N; Plundrich D; Arlt A; Röcken C; Sebens S; Schäfer H
    Oncogene; 2018 Jan; 37(1):39-51. PubMed ID: 28846107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.
    Curry JM; Tuluc M; Whitaker-Menezes D; Ames JA; Anantharaman A; Butera A; Leiby B; Cognetti DM; Sotgia F; Lisanti MP; Martinez-Outschoorn UE
    Cell Cycle; 2013 May; 12(9):1371-84. PubMed ID: 23574725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.
    Martinez-Outschoorn UE; Curry JM; Ko YH; Lin Z; Tuluc M; Cognetti D; Birbe RC; Pribitkin E; Bombonati A; Pestell RG; Howell A; Sotgia F; Lisanti MP
    Cell Cycle; 2013 Aug; 12(16):2580-97. PubMed ID: 23860378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.
    Whitaker-Menezes D; Martinez-Outschoorn UE; Lin Z; Ertel A; Flomenberg N; Witkiewicz AK; Birbe RC; Howell A; Pavlides S; Gandara R; Pestell RG; Sotgia F; Philp NJ; Lisanti MP
    Cell Cycle; 2011 Jun; 10(11):1772-83. PubMed ID: 21558814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.
    Mikkilineni L; Whitaker-Menezes D; Domingo-Vidal M; Sprandio J; Avena P; Cotzia P; Dulau-Florea A; Gong J; Uppal G; Zhan T; Leiby B; Lin Z; Pro B; Sotgia F; Lisanti MP; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):218-225. PubMed ID: 29248133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
    Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
    Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Chou CH; Chiang CF; Yang CC; Liu YC; Chang SR; Chang KW; Lin SC
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism.
    Wu DH; Liang H; Lu SN; Wang H; Su ZL; Zhang L; Ma JQ; Guo M; Tai S; Yu S
    Cell Physiol Biochem; 2018; 50(3):924-935. PubMed ID: 30355947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer.
    Pértega-Gomes N; Vizcaíno JR; Attig J; Jurmeister S; Lopes C; Baltazar F
    BMC Cancer; 2014 May; 14():352. PubMed ID: 24886074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
    Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
    Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal-epithelial lactate shuttle induced by tumor‑derived interleukin‑1β promotes cell proliferation in oral squamous cell carcinoma.
    Wu J; Hong Y; Wu T; Wang J; Chen X; Wang Z; Cheng B; Xia J
    Int J Mol Med; 2018 Feb; 41(2):687-696. PubMed ID: 29207019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma.
    Gooptu M; Whitaker-Menezes D; Sprandio J; Domingo-Vidal M; Lin Z; Uppal G; Gong J; Fratamico R; Leiby B; Dulau-Florea A; Caro J; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):204-217. PubMed ID: 29248132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
    Lee JY; Lee I; Chang WJ; Ahn SM; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Cho JH; Kim SY; Kim KM; Lee S; Kim ST; Park SH; Lee J; Park JO; Park YS; Lim HY; Kang WK
    Oncotarget; 2016 Jul; 7(28):43492-43503. PubMed ID: 27224918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells.
    Walters DK; Arendt BK; Jelinek DF
    Cell Cycle; 2013 Oct; 12(19):3175-83. PubMed ID: 24013424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes.
    Vaz CV; Marques R; Alves MG; Oliveira PF; Cavaco JE; Maia CJ; Socorro S
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):5-16. PubMed ID: 26048031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.